<DOC>
	<DOC>NCT02143362</DOC>
	<brief_summary>The study designed to explore the efficacy and safety of the closed loop of target controlled infusion dexmedetomidine combined with propofol for anesthesia with intraoperative wake up.</brief_summary>
	<brief_title>Dexmedetomidine Combined With the Closed Loop of Target Controlled Infusion of Propofol for Anesthesia With Intraoperative Wake up</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<criteria>Written informed consent. Ongoing brain functional area surgery with intraoperative wake up. American Society of Anesthesiologists class I to II. Aged between 18 and 65 years old. Weight between plus or minus 20% of the standard weight. Male: (height cm 80) × 70% = standard weight Female: (height cm 70) × 60% = standard weight History of hypertension. Serious heart,brain,liver,kidney, pulmonary, and endocrine disease or serious infection. Mental disability or mental disease. Use of sedative drug. Suspected or confirmed long term use of narcotic analgesics. Inability to exchange. Suspected or confirmed difficult airway. Suspected of malignant hyperthermia. Neuromuscular disease. Allergic to investigational products or with other contraindication. Subjects who are breastfeeding or pregnant. Participated in other study within 30 days .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Intraoperative wake up</keyword>
	<keyword>Closed loop of target controlled infusion</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Propofol</keyword>
</DOC>